| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Piportil Depot 50mg/1ml solution for injection ampoules (JHC Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Glycopyrronium bromide 200micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Robinul 200micrograms/1ml solution for injection ampoules (Goldshield Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Enoxaparin sodium 40mg/0.4ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Clexane 40mg/0.4ml solution for injection pre-filled syringes (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Enoxaparin sodium 20mg/0.2ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Clexane 20mg/0.2ml solution for injection pre-filled syringes (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Generic Sustanon 100 solution for injection 1ml ampoules 6 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sustanon 100 solution for injection 1ml ampoules (Organon Laboratories Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dalteparin sodium 12,500units/0.5ml solution for injection pre-filled syringes 5 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fragmin 12,500units/0.5ml solution for injection pre-filled syringes (Pfizer Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dalteparin sodium 2,500units/0.2ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fragmin 2,500units/0.2ml solution for injection pre-filled syringes (Pfizer Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gentamicin 80mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gentamicin 80mg/2ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gentamicin 80mg/2ml solution for injection ampoules 25 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gentamicin 80mg/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cidomycin 80mg/2ml solution for injection ampoules (Sanofi) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gentamicin 80mg/2ml solution for injection ampoules (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Genticin Injectable 80mg/2ml solution for injection ampoules (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gentamicin 80mg/2ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Efcortesol 100mg/1ml solution for injection ampoules (Sovereign Medical) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Lidocaine 100mg/20ml (0.5%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials 5 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Xylocaine 0.5% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 2ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 2ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 2ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 2ml ampoules (The Boots Company) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 2ml ampoules (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 2ml ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Octreotide 1mg/5ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Phytomenadione 1mg/0.5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Octreotide 50micrograms/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Konakion Neonatal 1mg/0.5ml solution for injection ampoules (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Midazolam 10mg/5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Midazolam 10mg/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Midazolam 10mg/5ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Nandrolone 50mg/1ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Deca-Durabolin 50mg/1ml solution for injection ampoules (Organon Laboratories Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Midazolam 10mg/5ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hypnovel 10mg/5ml solution for injection ampoules (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cyclizine tartrate 50mg/1ml / Morphine tartrate 15mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cyclimorph 15 solution for injection 1ml ampoules (CeNeS Pharmaceuticals) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cyclizine tartrate 50mg/1ml / Morphine tartrate 10mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cyclimorph 10 solution for injection 1ml ampoules (CeNeS Pharmaceuticals) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium chloride 0.9% solution for injection 500ml polyethylene bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Polyfusor S sodium chloride 0.9% solution for injection 500ml bottles (Fresenius Kabi Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium chloride 0.9% solution for injection 1litre polyethylene bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Polyfusor S sodium chloride 0.9% solution for injection 1litre bottles (Fresenius Kabi Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcitonin (salmon) 100units/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Miacalcic 100units/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calsynar 100units/1ml solution for injection ampoules (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 3,500units/0.35ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Innohep 3,500units/0.35ml solution for injection pre-filled syringes (LEO Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 10,000units/0.5ml solution for injection pre-filled syringes 2 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 10,000units/0.5ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Innohep 10,000units/0.5ml solution for injection pre-filled syringes (LEO Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 14,000units/0.7ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 14,000units/0.7ml solution for injection pre-filled syringes 2 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Innohep 14,000units/0.7ml solution for injection pre-filled syringes (LEO Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 18,000units/0.9ml solution for injection pre-filled syringes 2 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 18,000units/0.9ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Innohep 18,000units/0.9ml solution for injection pre-filled syringes (LEO Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Lorazepam 4mg/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ativan 4mg/1ml solution for injection ampoules (Wyeth Laboratories) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Salbutamol 500micrograms/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ventolin 500micrograms/1ml solution for injection ampoules (GlaxoSmithKline) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Glyceryl trinitrate 50mg/50ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Nitronal 50mg/50ml solution for infusion vials (Beaumont Pharma Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Haloperidol 20mg/2ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Serenace 20mg/2ml solution for injection ampoules (IVAX Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Nitrocine 50mg/50ml solution for injection vials (Schwarz Pharma Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Glyceryl trinitrate 5mg/5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Nitronal 5mg/5ml solution for infusion ampoules (Beaumont Pharma Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Buserelin 5.5mg/5.5ml solution for injection vials 2 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Suprefact 5.5mg/5.5ml solution for injection vials (Neon Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Suprecur 5.5mg/5.5ml solution for injection vials (Neon Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Betamethasone 4mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Betnesol 4mg/1ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline hydrochloride 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Acetylcysteine 2g/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Minijet adrenaline 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes 21 gauge (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Parvolex 2g/10ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Minijet adrenaline 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes 25 gauge (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Certoparin sodium 3,000units/0.3ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Alphaparin 3,000units/0.3ml solution for injection pre-filled syringes (Grifols UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 500micrograms/0.5ml (1 in 1,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 500micrograms/0.5ml (1 in 1,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 500micrograms/0.5ml (1 in 1,000) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 500micrograms/0.5ml (1 in 1,000) solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Atropine 600micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|